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Abstract
Background: Obstructive jaundice poses diagnostic and therapeutic challenges to general surgeons practicing in
resource-limited countries. This study was undertaken to highlight the etiological spectrum, treatment outcome of
obstructive jaundice in our setting and to identify prognostic factors for morbidity and mortality.
Methods: This was a descriptive prospective study which was conducted at Bugando Medical Centre between July
2006 and June 2010. All patients with a clinical diagnosis of obstructive jaundice were, after informed consent for
the study, consecutively enrolled into the study. Data were collected using a pre-tested structured questionnaire
and analyzed using SPSS computer software version 11.5.
Results: A total of 116 patients were studied. Females outnumbered males by a ratio of 1.3:1. Patients with
malignant obstructive jaundice were older than those of benign type. Ca head of pancreas was the commonest
malignant cause of jaundice where as choledocholithiasis was the commonest benign cause. Abdominal
ultrasound was the only diagnostic imaging done in all patients and revealed dilated intra and extra-hepatic
ducts, common bile stones and abdominal masses in 56.2%, 78.9%, 58.1% and 72.4% of the cases respectively. A
total of 110 (94.8%) patients underwent surgical treatment and the remaining 6 (5.2%) patients were unfit for
surgery. The complication rate was 22.4% mainly surgical site infections. The mean hospital stay and mortality
rate were 14.54 days and 15.5% respectively. A low haematocrit and presence of postoperative sepsis were the
main predictors of the hospital stay (P < 0.001), whereas age > 60 years, prolonged duration of jaundice,
malignant causes and presence of postoperative complications mainly sepsis significantly predicted mortality (P
< 0.001).
Conclusion: Obstructive jaundice in our setting is more prevalent in females and the cause is mostly malignant.
The result of this study suggests that early diagnosis and treatment plays an important role in the prognosis of
patients with obstructive jaundice.
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Obstructive Jaundice is a common surgical problem that
occurs when there is an obstruction to the passage of
conjugated bilirubin from liver cells to intestine [1]. It is
among the most challenging conditions managed by
general surgeons and contributes significantly to high
morbidity and mortality [2]. As patients with obstructive
jaundice have high morbidity and mortality, early diag-
nosis of the cause of obstruction is very important espe-
cially in malignant cases, as resection is only possible at
that stage [1-4].
Jaundice due to biliary obstruction may be caused by a
heterogeneous group of diseases that include both
benign and malignant conditions [5]. The common
etiologies of obstructive jaundice have been reported to
vary from one centre to another and from one indivi-
dual to another [5,6]. Obstructive jaundice is not a defi-
nitive diagnosis and early investigation to elucidate the
precise etiology is of great importance because patholo-
gical changes (e.g. secondary biliary cirrhosis) can occur
if obstruction is unrelieved [7]. A vast array of invasive
and non invasive diagnostic tests is available to diagnose
and establish the etiology of surgical obstructive jaun-
dice [4,7]. Invasive tests may cause cholangitis and ima-
ging techniques like computed tomography (CT) scan,
PTC, ERCP and MRCP are expensive and are not read-
ily available in most centers in developing countries
[7-10], and ultrasonography remains the only diagnostic
test available [4,11].
The management of obstructive jaundice poses diag-
nostic and therapeutic challenges to general surgeons
practicing in resource-limited countries [2,12]. Late pre-
sentation of the disease coupled with lack of modern
diagnostic and therapeutic facilities are among the hall-
marks of the disease in developing countries [12]. Sur-
gery in jaundiced patients is associated with a higher
risk of postoperative complications compared with sur-
gery in non jaundiced patients [13,14]. These complica-
tions primarily consist of septic complications
(cholangitis, abscesses, and leakage), hemorrhage,
impaired wound healing and renal disorders [14].
The outcome of treatment of obstructive jaundice may
be poor especially in developing countries where
advanced diagnostic imaging and therapeutic facilities
are not readily available in most centers [6]. The mortal-
ity and morbidity of biliary obstruction are dependent
on the cause of the obstruction, and the assessment of
any factors which influence the morbidity and mortality
in patients with obstructive jaundice in each society is
necessary [6,15]. It has been reported that obstructive
jaundice continues to be associated with significant
morbidity and mortality despite recent advances both in
preoperative diagnosis and postoperative care [15-17].
Understanding factors responsible for increased
morbidity and mortality in these patients will better
guide appropriate management and lead to improved
survival [17].
There is paucity of information regarding the manage-
ment of obstructive jaundice in our environment as
there is no local study which has been done in our set-
ting particularly the study area.
This study was undertaken to describe our own
experiences in the management of obstructive jaundice,
outlining the etiological spectrum, treatment outcome
and prognostic factors for morbidity and mortality in
our local setting.
Methods
This was a prospective study of patients with a clinical
diagnosis of obstructive jaundice admitted to the surgi-
cal wards of Bugando Medical Centre (BMC) over a 5-
year period between July 2006 and June 2010. Bugando
Medical Centre is a consultant and teaching hospital for
the Weill Bugando University College of Health Sciences
and has a bed capacity of 1000. It is situated in Mwanza
City, in north-western Tanzania. It is a referral centre
for tertiary specialist care for six regions, including
Mwanza, Mara, Kagera, Shinyanga and Kigoma. It serves
catchments population of approximately 13 million
people.
During this study, all patients who were admitted to
the surgical wards of BMC with a clinical diagnosis of
obstructive jaundice were, after informed written con-
sent, consecutively recruited into the study. Patients
with medical jaundice were excluded from the study.
Ethical approval to conduct the study was obtained
from the WBUCHS/BMC joint institutional ethic review
committee before the commencement of the study.
All the patients were subjected to detailed history,
clinical examination, laboratory investigations which
included the Liver Function tests to see the bilirubin
level and the level of serum alkaline phosphatase and
ALT and AST. Other laboratory investigations included
WBC count, Packed RBC volume, Prothrombin Time,
serum creatinine and albumin. Abdominal Ultrasound
was the only diagnostic imaging done in all patients to
look for the abnormality of intra and extra-hepatic bili-
ary channels, the common bile duct and presence of
causative factors like gall tones, tumors, lymph nodes,
worms or any abdominal mass. Advanced diagnostic
imaging such as CT scan abdomen, ERCP, PTC and
MRCP were not done in any of our patients as these
facilities are not available at our centre.
The patients were assessed preoperatively, intraopera-
tively and postoperatively, and the findings were
recorded in a pre-tested structured questionnaire.
Details that were recorded included patients’ biodata,
duration of jaundice, cause of obstructive jaundice,
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ment modalities, intraoperative findings, post-operative
complications, length of hospital stay and mortality. Pre-
operative preparations included maintaining good hydra-
tion and administration of antibiotics, intravenous dex-
trose (10%) solution and Vitamin K injections. In
anemic patients blood transfusion was also carried out.
During surgery intravenous Mannitol was used in all the
patients. The nature of surgical procedure carried out
depended upon the cause and the findings at the time
of surgery. Patients were followed up till discharge or
death.
Data analysis was done using SPSS computer software
version 11.5. Results were reported as percentages for
categorical variables. The variables were compared using
the Chi-square test or Fisher’s exact test if required for
categorical variables. Predictors exhibiting a statistically
significant relationship with outcome variables in the
univariate analysis (p-value less than 0.05) were taken
for a multivariate logistic regression analysis to investi-
gate their independence. Odds ratios (OR) and 95% con-
fidence intervals (CI) for OR were calculated. A p- value
of less than 0.05 was considered statistically significant.
Results
During the period under study, a total of 116 patients of
obstructive jaundice were enrolled. Of these, 50 (43.1%)
were males and females were 66 (56.9%) with a male to
female ratio of 1:1.3. Their ages ranged from 12 to 78
years with a mean of 56.34 ± 16.42 years. The mean age
of patients with benign causes was 42.56 ± 22.12 years
(range 12-48 years), while that of malignant causes was
58.64 ± 24.14 years (range 44-78 years). The difference
in age distribution of the benign and malignant disease
was statistically significant (P < 0.001). Both the benign
and malignant obstructive jaundice were found to be
more commonly amongst the females than males. The
male to female ratio for benign obstructive jaundice was
1:2.5, while it was 1:1.4 for the malignant obstructive
Jaundice. This difference was statistically significant (P <
0.001).
The etiology of obstructive jaundice was benign in 48
(41.4%) cases, whereas 68(58.6%) patients had malignant
cause. Choledocholithiasis was the commonest cause
among the benign group in 30 (62.5%) patients, whereas
the commonest tumor among the malignant group was
carcinoma of the head of pancreas in 44 (64.7%)
patients. Table 1 indicates the different causes of
obstructive jaundice.
The duration of illness ranged from 5 to 32 days with
a mean and median of 16.34 ± 12.30 days and 16.00 ±
14.22 days respectively. The clinical presentation of
obstructive jaundice for both benign and malignant
etiology is shown in Table 2.
Liver function tests were done in all cases and they
show raised levels of Bilirubin and Alkaline Phosphatase
in both benign and malignant groups. The differences in
serum Bilirubin and Alkaline Phosphatase levels in these
two groups were not statistically significant (P > 0.05).
Serum ALT levels were elevated in 72 (62.1%) of cases.
Mean serum bilirubin in patients was 17.1 mg/dL on
admission and fell to 2.6 mg/dL after two weeks post
surgery (p < 0.05),
Abdominal ultrasound was the only diagnostic ima-
ging done in all patients and revealed dilated intra and
extra-hepatic ducts in 56.2% and 78.9% of the cases
respectively. Common bile duct stones were detected in
only 58.1% of patients. Abdominal masses were detected
in 72.4% of the cases. CT scan, ERCP, PTC and MRCP
were not performed as they are not available in our
institution.
A total of 110 (94.8%) patients underwent open surgi-
cal treatment and the remaining 6 (5.2%) patients were
found to be unfit for surgery and were treated conserva-
tively. Of the patients who were unfit for surgery, two
patients had benign jaundice due to chronic pancreatitis
and choledocholithiasis in a sickler patient with severe
anemia. The remaining four patients had malignant
jaundice. None of our patients had non-surgical proce-
dures such as stricture dilatation and stent placement.
Table 1 Causes of obstructive jaundice
Causes of obstructive jaundice Number of
patients
Percentage
Benign causes 48 41.4
Choledocholithiasis 30 62.5
Biliary strictures 12 25.0
Chronic pancreatitis 3 6.3
Amoebic hepatic abscess 1 2.1
Cause not identified 4 8.3
Malignant causes 68 58.6
Ca head pancreas 44 64.7
Cholangiocarcinoma 8 11.8
Ca gallbladder 6 8.8
Peri-ampulary Ca 6 8.8
Metastatic malignant lymph nodes in
the portal hepatic
4 5.9
Table 2 Clinical presentation of obstructive jaundice
Clinical feature Benign Malignant Total
Jaundice 48(41.4%) 68(58.6%) 116(100%)
Clay colored stool 42(36.2%) 62(53.4%) 104(89.6%)
Pruritis 40(34.5%) 50(43.1%) 90(77.6%)
Weight loss 5(4.3%) 66(56.9%) 71(61.2%)
Right upper abdominal pain 48(41.4%) 20(17.2%) 68(58.6%)
Scratch marks 30(25.9%) 32 (27.6%) 62(53.4%)
Abdominal mass 1(0.9%) 59(50.9%) 60(51.8%)
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available at our centre. The type of surgical procedures
done is shown in Table 3.
Major surgeries like pancreatoduodenectomy, hepa-
tectomy and Whipple’s procedure were not performed
as majority of patients requiring these procedures pre-
sented late with advanced disease and the only treat-
ment option was palliative surgery.
Thirty two complications were recorded in 26 patients
giving a complication rate of 22.4%. Of these, postopera-
tive wound sepsis was the most common complications.
The detail of complications is shown in table 4
The overall length of hospital stay ranged from 5
days to 44 days (mean 14.54 ± 26 days). 18 patients
d i e dg i v i n gam o r t a l i t yr a t eo f1 5 . 5 % .T h ec a u s e so f
death were postoperative sepsis in 6 (33.3%) patients,
advanced malignant in 5 (27.8%) patients, renal failure
in 2 (11.1%) patients, disseminated intravascular coagu-
lopathy in 2 (11.1%) patients, associated HIV infection
in 2 (11.1%) patients, hepat i cc o m aa n dc a r d i a ca r r e s t
in 1 (5.6%) patient each respectively. A low haemato-
crit and presence of postoperative sepsis were the
main predictors of the hospital stay (P < 0.001),
whereas age > 60 years, prolonged duration of jaun-
dice, malignant causes and presence of postoperative
complications mainly sepsis significantly predicted
mortality (P < 0.001).
Discussion
Obstructive jaundice poses diagnostic and therapeutic
challenges to general surgeons and contributes signifi-
cantly to high morbidity and mortality [2]. The chal-
lenge is even more conspicuous in developing countries
like Tanzania where delayed presentation of the disease
coupled with lack of modern diagnostic (e.g. CT scan,
PTC, ERCP and MRCP) and therapeutic facilities (e.g.
T-tubes) are among the hallmarks of the disease [12].
This study was conducted in our local setting to
describe our own experiences in the management of this
challenging disease; the problem not previously studied
at our centre or any other hospital in the country.
The majority of patients in this study had malignant
obstructive jaundice which is in agreement with other
studies reported elsewhere [1,4,6,8,18,19], but in contrast
to Bekele et al [12] in Ethiopia who reported benign
obstructive jaundice (choledocholithiasis) as the most
common cause of obstructive jaundice. In our study,
carcinoma of the head of pancreas was the commonest
cause of malignant obstructive jaundice while choledo-
cholithiasis was the commonest benign cause. Similar
observation was also noted by others [8,18,19]. Sharm &
Ahuja [4] reported carcinoma of the gall bladder as the
most common cause of malignant obstructive jaundice.
Also, studies in Saudi Arabia and Yemen reported
Ascariases Lumbricoides to be frequently associated with
disease of biliary tract resulting in obstruction [20].
These observations reflect differences in etiological spec-
trum from one centre to another.
In this study, both the benign and malignant obstruc-
tive jaundice were found to be more common in females
than in males, which is in conformity with the results of
other researchers [1,4,8,18]. Female preponderance in
both the benign and malignant obstructive jaundice has
been ascribed to high prevalence of gall stones in them
which is reported to be a risk factor for many benign
and malignant conditions causing biliary obstruction
[21-23].
Most of the patients with benign obstructive jaundice
in our study were in younger age group while malignant
causes were in elder age group. The incidence of malig-
nant obstructive jaundice in patients of older age group
was also reported by others [6,8,18,19].
All patients in our study presented with jaundice asso-
ciated with clay colored stool (89.6%), pruritis (77.6%),
weight loss (61.2%), right upper abdominal pain (58.6%),
scratch marks (53.6%) and palpable abdominal mass
(51.8%). Clay colored stool, weight loss and palpable
abdominal mass were more common in malignant
obstructive jaundice, whereas right upper abdominal
p a i nw a sm o r ec o m m o ni nb e n i g no b s t r u c t i v ej a u n d i c e .
Pruritis and scratch marks were seen equally in both the
benign and malignant cases. Similar clinical pattern was
also reported by others [1,8,12,18]. The presence of
Table 3 Type of surgical procedure performed (N = 110)
Type of surgical procedure Number of
patients
Percentage
Cholecystojejunostomy 64 58.2
Choledocholithotomy
±Cholecystectomy
18 16.4
Choledochoduodenostomy 10 9.1
Exploratory laparotomy/inoperable 7 6.4
Tumor resection 6 5.5
Hepaticojejunostomy 4 3.4
Drainage of abscess 1 0.9
Table 4 Complications of treatment
Complications Number of patients Percentage
Surgical site infections 20 62.5
Coagulopathy 3 9.4
Renal failure 2 6.3
Wound dehiscence 2 6.3
Abdominal abscess/Peritonitis 2 6.3
Hepatic coma 1 3.1
Pneumonia 1 3.1
Leakage of bile 1 3.1
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obstructive jaundice is probably due to advanced dis-
ease. The abdominal mass was appreciated in 50.9% of
the patients with malignancy due to the local spread of
tissues and no mass was palpable in cases of choledo-
cholithiasis or any other benign condition thus support-
ing the ‘Courvoisier’s law [8,19,24].
The biochemical investigations done was liver function
tests which showed high serum bilirubin and alkaline
phosphatase levels. The difference in serum bilirubin
and alkaline phosphatase levels between benign and
malignant obstructive jaundice was not statistically sig-
nificant. This finding is in agreement with other studies
[8,18]. In one study by Cheema et al [25], the values of
bilirubin and alkaline phosphatase were found to be
higher in the malignant cases.
Patients with obstructive jaundice have increased levels
of serum bilirubin and most of the complications in the
preoperative and postoperative period in obstructive jaun-
dice have been attributed to hyperbilirubinemia [26]. Fol-
lowing definitive surgery to relieve obstruction, there is a
significant fall in serum bilirubin levels. The time taken for
achieving a significant drop in serum bilirubin levels may
vary from 4 days to 3 weeks after definitive surgery [27].
Afify et al [28] reported a significant fall in serum bilirubin
levels. This agrees to the results of our study. Definitive
surgery to relieve obstructive jaundice plays a greater role
in reversing the pathophysiological disturbances associated
with obstructive jaundice and thus reduce postoperative
morbidity and mortality [26-28].
In places where advanced diagnostic imaging (e.g. CT
scan, ERCP, PTC and MRCP) are not available as in
most centers in developing countries, abdominal ultra-
sound has been reported to be the first and best initial
imaging procedure in patients who have obstructive
jaundice and shows reasonable sensitivity and specificity
to identify causes of obstruction in obstructive jaundice
[4,11,12,19,25]. Abdominal ultrasound was the only
diagnostic imaging done in all our patients as most of
the advanced radiological tests such as abdominal CT
scan, ERCP, PTC and MRCP are not available at our
centre. This observation is common in most studies in
developing countries [12,11,29].
In our study, the majority of patients with malignant
obstructive jaundice underwent palliative surgery mainly
by bypass surgery, whereas the majority of patients with
benign obstructive jaundice underwent curative surgery.
Similar treatment pattern was also reported by
Mohammed et al [1]. High incidence of palliative sur-
gery in patients with malignant obstructive jaundice is
due to delayed presentation for treatment as a result the
majority of patients with malignant conditions report to
hospital very late when the disease is in advanced stage,
and the only option is palliative surgery.
Since surgery in patients with jaundice is thought to
increase the risk of postoperative complications, preo-
perative biliary drainage {PBD) was introduced as means
of reversing the pathophysiological disturbance seen in
jaundiced patients and has been advocated before cura-
tive tumor resection by some surgeons to decrease the
complications of biliary surgery in the jaundiced patients
[30]. Early studies showed a reduction in morbidity [16].
However, more recently the focus has shifted towards
the negative effects of drainage, such as an increase
increased incidence of postoperative morbidity [mostly
infectious complications] and postoperative mortality
[31]. Whether biliary drainage should always be per-
formed in jaundiced patients remains controversial. The
use of PBD has not been evaluated in our setting and
therefore none of our patient in this series underwent
PBD. It is therefore recommended that, a prospective
randomized trial addressing the effects of PBD, and thus
solving the longstanding controversy whether or not
PBD should be routinely performed in jaundiced
patients prior to a surgery, is highly indicated in our set-
ting so as to justify its benefits.
Traditionally, T-tube placement after common biliary
duct exploration has long been a standard surgical practice
for choledocholithiasis, but potential of complications
exists with this therapeutic modality [29,31]. These include
sepsis, dislodgement of tube, obstruction and/or fracture
of tube, leakage of bile, incomplete evacuation, recurrent
stone and patient may have to carry it for several weeks
before removal. All of these lead to prolong length of hos-
pital stay [31,32]. The use of T-tube has been challenged
by recent clinical trials which advocated primary closure
of common bile duct after open Choledocholithotomy for
Choledocholithiasis [31-34]. In our study, primary closure
of common bile duct after open Choledocholithotomy for
Choledocholithiasis was used in the majority of patients as
T-tubes are not available in our centre.
In our study, complication rate was recorded in 22.4%
of cases. Of this, surgical site infection was the most
common postoperative complications and the most
found organisms were E. coli, Klebsiella and Proteus.
Similar bacterial profile was also found in other studies
[35]. Postoperative wound infections in biliary surgery
has been reported in literature to be due to contamina-
tion by gram negative enteric aerobes like E. coli, Kleb-
siella and Proteus produced by opening the biliary tract
in patients with bactibilia [36-38]. High incidence of
these organisms in our study may be due to contamina-
tion of the wound during the surgical procedure.
The figure for the overall duration of hospital stay in
our study was higher than that reported in other studies
[6,13,14]. The predictors of the length of hospital stay
were low haematocrit and presence of postoperative
sepsis.
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dice has been reported to be associated with significant
mortality compared with surgery in non jaundiced
patients [13-15,31]. Mortality rates of between eight and
33% have been reported for surgery to relieve bile duct
obstruction [13,16,17].
Several factors including elder age group, duration of
jaundice, malignant causes, high levels of bilirubin and
presence postoperative complications (e.g. sepsis, coagu-
lopathy, hepatic coma and renal failure) have been
reported in literature to be associated with high mortal-
ity rate in these patients [6,13,15]. Our mortality rate of
15.5% was higher that reported in an Iranian study by
Mehrdad et al [6]. The predictors of mortality in our
study were age > 60 years, prolonged duration of jaun-
dice, malignant causes and presence postoperative com-
plications mainly sepsis.
The high morbidity and mortality rates in this study are
attributed to delayed presentation of disease and lack of
modern diagnostic and therapeutic facilities seen in devel-
oped world. Findings from this study is a typical example
of diagnostic and therapeutic challenges seen in most
developing countries where delayed presentation of the
disease coupled with lack of modern diagnostic (e.g. CT
scan, PTC, ERCP and MRCP) and therapeutic facilities (e.
g. T-tubes) are among the hallmarks of the disease.
Conclusion
Obstructive jaundice is a common surgical problem in our
setting and poses diagnostic and therapeutic challenges. It
is more common among females with malignant causes
being more prevalent. The benign jaundice is seen in
young patients while malignant causes in elder age group.
Carcinoma of the head of pancreas is the commonest
malignant cause of jaundice whereas stones in the bile
duct the commonest benign etiology. Most of patients
with malignant obstructive jaundice present late with
advanced disease and the only treatment modality for
these patients was palliative surgery. The majority of
patients with Choledocholithiasis were treated with Chole-
docholithotomy and primary closure of the common bile
duct. The result of this study suggests that early diagnosis
and treatment plays an important role in the prognosis of
patients with obstructive jaundice. Primary closure of the
common bile duct is safe and cost effective alternative to
routine T-tube drainage after open Choledocholithotomy
and associated with low complication rates.
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